Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000276530 | SCV000431570 | uncertain significance | Congenital Myasthenic Syndrome, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001420846 | SCV001623253 | benign | not specified | 2021-04-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001520368 | SCV001729441 | benign | Congenital myasthenic syndrome 12 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001653625 | SCV001865277 | benign | not provided | 2019-08-27 | criteria provided, single submitter | clinical testing | |
Molecular Genetics, |
RCV001520368 | SCV004812366 | benign | Congenital myasthenic syndrome 12 | 2023-05-04 | criteria provided, single submitter | clinical testing | African population allele frequency is 53.11% (rs201931307, 80264/168730 alleles, 4671 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as BENIGN. Following criteria are met: BA1 |